• Chat
  • Dashboard
  • Daily Briefing
  • Discover
    • Feedback
    • Log in
    Log inGet Started

    First GLP-1 pill for obesity from Novo Nordisk launches in the U.S. - CNBC

    AI Summary1 min read

    TL;DR

    Novo Nordisk has launched the first GLP-1 pill for obesity in the U.S., offering a daily oral alternative to weekly injections like Wegovy, marking a significant shift in weight-loss drug options.

    Tags

    GLP-1 pillobesity treatmentNovo NordiskWegovyweight-loss drugs
    1. First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.  CNBC
    2. What to watch for in weight loss drugs in 2026: Price changes, GLP-1 pills and more  NBC News
    3. Starter dose of Wegovy now available as a daily pill instead of weekly injection  CNN
    4. The expanding landscape of GLP-1 medicines  Nature
    5. Novo launches Wegovy weight-loss pill for sale in US  Reuters

    Monday, January 5, 2026 1:00 PM

    Visit Website
    website-logo

    Top stories - Google News

    Google News

    channel icon
    Related Articles

    Lenovo expands AI lineup with Nvidia tie-up, Qira platform - Reuters

    Jan 7, 2026

    Teen killed by bus during ultra-Orthodox protest against conscription in Jerusalem - The Guardian

    Jan 7, 2026

    White House publishes website that rewrites history of Jan. 6 attack - The Washington Post

    Jan 7, 2026

    Justice Dept. Memo Approved Military Incursion Into Venezuela as Lawful - The New York Times

    Jan 7, 2026
    xgithub
    logo

    Copyright © 2022-2026 - Aetos.AI